Journals / Türk Psikiyatri Dergisi / 2012 / Cilt: 23 - Sayı: 4

Naltrexone treatment of kleptomania: A case report

Kleptomani tedavisinde naltrekson: Bir olgu sunumu

Pages
284–286
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

She also suffers from the comorbidities of major depressive disorder and obsessive compulsive disorder.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kleptomania is an impulse control disorder characterized by a recurrent failure to resist the impulse to steal worthless objects that are not needed for personal use.
📊
Key Findings & Data:Very little is known about the etiology, prevalence and treatment.
💡
Conclusion & Impact:She also suffers from the comorbidities of major depressive disorder and obsessive compulsive disorder.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Kleptomania is an impulse control disorder characterized by a recurrent failure to resist the impulse to steal worthless objects that are not needed for personal use. Very little is known about the etiology, prevalence and treatment. This disorder usually begins during puberty and lasts until late adulthood. In some patients, it may last throughout the person’s life. Patients with kleptomania are likely to suffer from comorbid conditions like mood disorders. The patients usually seek treatment for the comorbid psychiatric complaints, rather than the kleptomaniac behavior itself. The literature lacks sufficient knowledge and controlled studies about the treatment of kleptomania. Regarding the treatment of SSRIs, there are case reports and case series, using mood stabilizers, antipsychotics and opioid antagonists. Cognitive behavioral therapy techniques are also used in the treatment of kleptomania. In this study, a female patient is presented with diminishing kleptomaniac symptoms after naltrexone is added to her Cognitive behavioral therapy and fluoxetine treatment. She also suffers from the comorbidities of major depressive disorder and obsessive compulsive disorder.

Özet

Kleptomani, maddi değeri olmayan, kişisel kullanım için gereksinim duyulmayan nesnelere yönelik çalma dürtüsüne direnç gösterememe ile tanımlanan bir dürtü kontrol bozukluğudur. Etiyolojisi, yaygınlığı ve tedavisine ilişkin bilgiler sınırlıdır. Bu bozukluk genellikle ergenlik döneminde başlar ve geç erişkinliğe kadar sürer, bazı hastalarda ömür boyu sürebilir. Kleptomaniye genellikle başka ek tanılar örneğin duygudurum bozuklukları eşlik edebilmektedir. Kleptomani olan hastalar çoğunlukla kleptomani için değil eşlik eden diğer belirtileri için tedaviye başvururlar. Kleptomani tedavisi konusunda da yeterli bilgi ve kontrollü çalışma yoktur. Tedavisiyle ilgili olarak seçici serotonin gerialım inhibitörleri (SSGİ), duygudurum dengeleyiciler, antipsikotikler, opioid antagonistlerinin kullanıldığı olgu bildirimleri ve olgu serileri vardır. Tedavide bilişsel davranışçı terapi (BDT) yöntemleri de kullanılmaktadır. Bu yazıda, majör depresif bozukluk ve obsesif kompulsif bozukluk (OKB) ek tanıları olan, BDT ve fluoksetin tedavisine naltrekson eklendikten sonra kleptomani belirtilerinde azalma olan bir kadın hasta sunulmaktadır.

🔖

Cite This Article

AYDIN, P. Ç., GÜNGÖR, B. B., GÜLSEREN, L. (2012). Naltrexone treatment of kleptomania: A case report. Türk Psikiyatri Dergisi, Cilt: 23 - Sayı: 4, 284–286. https://ajindex.com/articles/88931

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Aizer A, Lowengrub K, Dannon PN (2004) Kleptomania after head trauma: Two case reports and combination treatment strategies. Clin Neuropharmacol, 27:211-5.
  2. Amerikan Psikiyatri Birliği (2007) Ruhsal Bozuklukların Tanısal ve Sayımsal Elkitabı, Dördüncü Baskı, Yeniden Gözden Geçirilmiș Tam Metin (DSMIV- TR), Washington DC, 2000, Köroğlu E (Çev. Ed.) Hekimler Yayın Birliği. Baylé FJ, Caci H, Millet B ve ark. (2003) Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry, 160:1509-13.
  3. Chong SA, Low BL (1996) Treatment of kleptomania with fluvoxamine. Acta Psychiatr Scand, 93:314-5.
  4. Çalıyurt O, Tamam L (2009) Kleptomanide Tedavi Seçenekleri. Psikiyatride Güncel Yaklaşımlar, 1:1-10.
  5. Durst R, Katz G, Teitelbaum A ve ark. (2001) Kleptomania: Diagnosis and treatment options. CNS Drugs, 15: 185-95.
  6. Figgitt DP, McClellan KJ (2000) Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs, 60:925-54.
  7. Grant JE (2006) Understanding and treating kleptomania: New models and new treatments. Isr J Psychiatry Relat Sci, 43:81-7.
  8. Grant JE, Odlaug BL (2008) Kleptomania: Clinical Characteristics and Treatment.Revista Brasileira de Psiquiatria, 30: 11-5.
  9. Grant JE, Kim SW (2002a) Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry, 43:378-84.
  10. Grant JE, Kim SW (2002b) Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry, 11: 92-5.
  11. Grant JE, Kim SW (2002c) An Opel Label Study of Naltrexone in the treatment of Kleptomania. Journal of Clinical psychiatry, 63:349-56.
  12. Grant JE, Kim SW, Odlaug BL (2009) A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry, 65:600-6.
  13. Grant JE, Levine L, Kim D ve ark. (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry, 162:2184-8.
  14. Grant JE, Potenza MN (2004) Impulse control disorders: Clinical characteristics and pharmacological management. Ann Clin Psychiatry, 6:27-34.
  15. Grant JE (2005) Outcome study of kleptomania patients treated with naltrexone:A chart review. Clinical neuropharmacology, 28: 11-4.
  16. Hocaoğlu Ç, Kandemir G (2004) Kleptomani tedavisinde seçici serotonin gerialım engelleyicisi (SSRI) kullanımı: Üç olgunun sunumu. Klinik Psikofarmakoloji Bülteni, 14:204-8.
  17. Kim SW (1998) Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry, 59:159-